These data are consistent with the view that activation of PDK4 by MR-RAR would promote glycolysis and suppress oxidative phosphorylation, hence promoting the Warburg effect that has been reported to offer proliferative advantage to cancer cells. The gene discussed is NR3C2; the disease is cancer.